FDA Drug Recalls

Recalls / Class II

Class IID-1249-2022

Product

Bupivacaine HCl 150 mg (3.0 mg/mL), Ketorolac Tromethamine 60 mg (1.2 mg/mL), Ketamine HCl 60 mg (1.2 mg/mL) Injection, 50 mL syringes, packaged in 5 x 50 mL Pre-Filled Syringes per carton, 6 x 5 Syringe Carton per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-514-50

Affected lot / code info
Lots: BP2001A, Exp. 7/6/2022; BP2002A, Exp. 7/27/2022; BP2007A, Exp. 7/3/2022

Why it was recalled

Lack of Assurance of Sterility

Recalling firm

Firm
Nephron Sterile Compounding Center LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
4500 12th Street Ext, N/A, West Columbia, South Carolina 29172-3025

Distribution

Quantity
2315 syringes
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2022-06-30
FDA classified
2022-07-18
Posted by FDA
2022-07-27
Terminated
2024-06-17
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1249-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.